Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients

Clinical Microbiology and Infection

Volumn 22, Issue 7, 2016, Pages 607-612

  Mzabi, A ^a   Kerneis S ^a,b   Richaud, C ^a,b   Podglajen, I ^a,b   Fernandez Gerlinger, M P ^a,b   Mainardi, J L ^a,b,c  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Cohort study; Infective endocarditis; Mortality; Oral antibiotic therapy; Reinfections; Relapses

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLINDAMYCIN; QUINOLONE DERIVATIVE; RIFAMPICIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; CANDIDA PARAPSILOSIS; CHILD; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; FEMALE; FOLLOW UP; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PSEUDOMONAS STUTZERI; REINFECTION; RELAPSE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; VERY ELDERLY; ENDOCARDITIS; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT FAILURE; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; ENDOCARDITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT FAILURE; YOUNG ADULT;

EID: 84981268263     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2016.04.003     Document Type: Article

References (19)

1. [1] Hoen, B., Duval, X., Clinical practice. Infective endocarditis. N Engl J Med 368 (2013), 1425–1433.
2. [2] Selton-Suty, C., Célard, M., Le Moing, V., Doco-Lecompte, T., Chirouze, C., Iung, B., et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 54 (2012), 1230–1239.
3. [3] Lomas, J.M., Martínez-Marcos, F.J., Plata, A., Ivanova, R., Gálvez, J., Ruiz, J., et al. Healthcare-associated infective endocarditis: an undesirable effect of healthcare universalization. Clin Microbiol Infect 16 (2010), 1683–1690.
4. [4] Hoen, B., Chirouze, C., Cabell, C.H., Selton-Suty, C., Duchêne, F., Olaison, L., et al. Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis. Eur J Clin Microbiol Infect Dis 24 (2005), 12–16.
5. [5] Que, Y.A., Moreillon, P., Infective endocarditis. Nat Rev Cardiol 8 (2011), 322–336.
6. [6] Habib, G., Lancellotti, P., Antunes, M.J., Bongiorni, M.G., Casalta, J.P., Del Zotti, F., et al. 2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36 (2015), 3075–3128.
7. [7] Baddour, L.M., Wilson, W.R., Bayer, A.S., Fowler, V.G. Jr., Tleyjeh, I.M., Rybak, M.J., et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 132 (2015), 1435–1486.
8. [8] Heldman, A.W., Hartert, T.V., Ray, S.C., Daoud, E.G., Kowalski, T.E., Pompili, V.J., et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 101 (1996), 68–76.
9. [9] Dworkin, R.J., Lee, B.L., Sande, M.A., Chambers, H.F., Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet 2 (1989), 1071–1073.
10. [10] Demonchy, E., Dellamonica, P., Roger, P.M., Bernard, E., Cua, E., Pulcini, C., et al. Audit of antibiotic therapy used in 66 cases of endocarditis. Med Mal Infect 41 (2011), 602–607.
11. [11] Al-Omari, A., Cameron, D.W., Lee, C., Corrales-Medina, V.F., Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review. BMC Infect Dis, 14, 2014, 140.
12. [12] Li, J.S., Sexton, D.J., Mick, N., Nettles, R., Fowler, V.G. Jr., Ryan, T., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30 (2000), 633–638.
13. [13] Fowler, V.G. Jr., Miro, J.M., Hoen, B., Cabell, C.H., Abrutyn, E., Rubinstein, E., et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293 (2005), 3012–3021.
14. [14] Peetermans, W.E., Hill, E.E., Herijgers, P., Claus, P., Herregods, M.C., Verhaegen, J., et al. Nosocomial infective endocarditis: should the definition be extended to 6 months after discharge. Clin Microbiol Infect 14 (2008), 970–973.
15. [15] Fournier, P.E., Thuny, F., Richet, H., Lepidi, H., Casalta, J.P., Arzouni, J.P., et al. Comprehensive diagnostic strategy for blood culture–negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 51 (2010), 131–140.
16. [16] Podglajen, I., Bellery, F., Poyart, C., Coudol, P., Buu-Hoï, A., Bruneval, P., et al. Comparative molecular and microbiologic diagnosis of bacterial endocarditis. Emerg Infect Dis 9 (2003), 1543–1547.
17. [17] Mainardi, J.L., Utili, R., Endocarditis. Cornaglia, G., Courcol, R., Herrmann, J.L., Kahlmeter, G., Peigue-Lafeuille, H., Vila, J., (eds.) European manual of clinical microbiology (Société Française de Microbiologie/European Society for Clinical Microbiology and Infectious Diseases), 1st ed., 2012, 111–114.
18. [18] Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). Eur Heart J 30 (2009), 2369–2413.
19. [19] Fernández-Hidalgo, N., Almirante, B., Tornos, P., González-Alujas, M.T., Planes, A.M., Galiñanes, M., et al. Immediate and long-term outcome of left-sided infective endocarditis. A 12-year prospective study from a contemporary cohort in a referral hospital. Clin Microbiol Infect 18 (2012), 522–530.